Tandem Mass Spectrometry of Sphingolipids: Application in Metabolic Studies and Diagnosis of Inherited Disorders of Sphingolipid Metabolism by Ladislav Kuchař et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Tandem Mass Spectrometry of Sphingolipids: 
Application in Metabolic Studies  
and Diagnosis of Inherited Disorders  
of Sphingolipid Metabolism 
Ladislav Kuchař, Befekadu Asfaw and Jana Ledvinová 
Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in 
Prague and General University Hospital in Prague 
Czech Republic 
1. Introduction 
Sphingolipids are an amazingly diverse category of lipids found in all eukaryotes and in 
some prokaryotes and viruses. They are primarily a component of plasma membranes and 
of intracellular organelle membranes, including those of the nucleus, mitochondria, 
endosomes, and lysosomes (Hirabayashi, et al., 2006; Kaushik, et al., 2006; R. Ledeen & Wu, 
2011; R. W. Ledeen & Wu, 2008; Prinetti, et al., 2009; van Meer, et al., 2008). Sphingolipids 
are also an important constituent of plasma lipoprotein classes (Schweppe, et al., 2010; 
Wiesner, et al., 2009) and of the multilamellar water barrier of the skin (Holleran, et al., 
2006). In addition, they are excreted in urine, mostly in the cellular debris of urinary 
sediment. Urinary sediment analysis, or  “indirect biopsy,” of kidney cellular elements 
(Desnick, et al., 1970) can provide information that helps to diagnose certain lysosomal 
storage diseases (Kitagawa, et al., 2005; Kuchar, et al., 2009; Whitfield, et al., 2001).           
Sphingolipids are a heterogenous group. Amide bonds link long-chain fatty acids to 
aminoalcohols from the sphingoid group, of which sphing-4-enin ({2S,3R,4R}-2-
aminooctadec-4-ene-1,3-diol, historically called sphingosine) and its saturated derivative 
(sphinganine) are the most abundant. Longer or shorter sphingoids, which may be saturated 
or hydroxylated, also occur in lesser quantities.   
The name sphingosine was chosen by German clinician and chemist J. L. W. Tchudichum in 
1884 to reflect the enigmatic, “Sphinx-like” properties of the sphingolipid compounds first 
isolated from the brain. Fatty acid variations include mostly C16-C24 acyl chains, which are 
often saturated but can also exhibit a degree of unsaturation or hydroxylation (e.g., C24:1, 
C24:1-OH fatty acids). The general name for N-acylated sphingoids is ceramide. 
Sphingomyelin and glycosphingolipids have a headgroup in the phosphodiester or glycosyl 
linkage to the hydroxyl on the carbon-1. The latter compounds are classified as either neutral 
glycosphingolipids with uncharged sugars (glucose, galactose, N-acetylglucosamine, N-
acetylglalactosamine and fucose) or acidic glycosphingolipids with ionized functional groups 
(sulfates) or charged sugar moieties (N-acetylneuraminic acid or “sialic” acid). 
Two examples of sphingolipid structures are shown in Fig. 1. 
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Fig. 1. GM1 ganglioside - a representative acidic sphingolipid; sphingomyelin - a 
representative phosphosphingolipid. 
The simplest glycosphingolipids are the monohexosylceramides glucosylceramide (GlcCer, 
Glcǃ1-1´Cer) and galactosylceramide (galactocerebroside, GalCer, Galǃ1-1´Cer). The latter is 
less abundant but is specific to neural tissue, where it is also present in a sulfated form 
(sulfatide). Galactosylceramide also gives rise to small Gala-series of glycosphingolipids 
(Tab. 1). Glucosylceramide is a key compound in sphingolipid metabolic pathways; more 
complex glycosphingolipids are derived from the stepwise elongation of the oligosaccharide 
chain in the Golgi compartment. The addition of ǃ-linked galactose yields lactosylceramide 
(LacCer, Galǃ1-4GlcǃCer), whose oligosaccharide chain is the precursor to the different core 
structures of more complex glycosphingolipids (Tab. 1).  These structures are specific to 
certain tissues: e.g., neolacto-series predominate in leukocytes,  lacto-series in secretory 
organs,  globo-series in erythrocytes and ganglio-series in nervous tissue (Schnaar, et al., 
2009). This diversity is related to the functional differences between the individual 
glycosphingolipids.  
The catabolism of sphingolipids occurs in acidic cell compartments, i.e. late endosomes 
and lysosomes. Degraded lipids are embedded in inner membranes rich in negatively 
charged lipids such as bis(monoacylglycero)phosphate (BMP) (Kolter & Sandhoff, 2010). 
Sequential degradation steps proceed from the non-reducing end of the oligosaccharide 
chain catalyzed by soluble lysosomal hydrolases. For lipids with oligosaccharide chains 
shorter than four sugars, the assistance of small sphingolipid activator proteins (the 
saposins A, B, C, or D or the GM2 activator protein) is required (Sandhoff, et al., 2001). 
The sphingoids and fatty acids produced can be degraded in the cytoplasm and processed 
through the salvage pathway, where they become the building blocks of new membranes 
(Kitatani, et al., 2008). They can also be used in the regulation systems that control cell 
function (Kolter & Sandhoff, 2010). 
Inherited defects in gene-coding enzymes or proteins involved in sphingolipid degradation 
result in the accumulation of non-degraded substrates in the lysosomes. “Traffic jams” in 
the endolysosomal system caused by the accumulation of lipids co-precipitated with other 
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hydrophobic substances severely impair cell function and lead to lysosomal storage diseases 
(sphingolipidoses) (Desnick, et al., 2001; Liscum, 2000; Sandhoff, et al., 2001; Schulze & 
Sandhoff, 2011; von Figura, et al., 2001). Studies of these defects, however, may unveil the 
complicated mechanisms of cell function and regulation. Recent information learned about 
the role of NPC1 and NPC2 proteins in the intracellular transport of cholesterol can serve as 
an example (Infante, et al., 2008; Kwon, et al., 2009; Storch & Xu, 2009; Xu, et al., 2008). 
Hitherto, more than 400 structurally distinct sphingolipid variants in mammals have been 
listed in SphinGOMAP© ( http://www.sphingomap.org and http://www.glycoforum.gr.jp) 
(Aug 2011). A detailed sphingolipid nomenclature is available at 
http://www.chem.qmul.ac.uk/iupac/lipid/lip1n2.html (Aug 2011) and 
http://www.chem.qmul.ac.uk/iupac/lipid/lip3n4.html (Aug 2011).  
 
 
Table 1. The major root structures of vertebrate glycosphingolipids. 
Physiological sphingolipid function at the cellular level is highly complex. Sphingolipids 
participate in many cellular events, including cell-cell recognition, the modulation of 
membrane protein functions, adhesions, intra- and extra-cellular signaling and many still 
undiscovered processes (Kitatani, et al., 2008). Their rigid, highly saturated character and 
ability to undergo hydrogen bonding and dipolar interactions predetermines them to cluster 
into semiordered structures called lipid microdomains – rafts, together with   cholesterol  
and specific set of proteins (Goldschmidt-Arzi, et al., 2011; Helms & Zurzolo, 2004; Holthuis, 
et al., 2003). They function as important mediators of membrane transport and signaling.  
In recent years, investigation of the metabolism and biological functions of sphingolipid 
biomolecules has increased (Wennekes, et al., 2009). As a result, more accurate methods of 
analyzing sphingolipids have been developed. A leading method of analysis, tandem mass 
spectrometry (tandem MS or MS/MS), provides high selectivity and sensitivity of 
measurement. Indisputable advantage of this technique is a possibility to identify various 
molecular species of different sphingolipid classes in crude biological samples.   
We will focus on the contribution of tandem mass spectrometry to the study of 
sphingolipids and the usefulness of the technique in diagnosing inherited disorders of 
sphingolipid degradation. The topics discussed will include the following: 
 Tandem mass spectrometry used to analyze sphingolipids in tissues, cells and urine 
(both the general approach used and its applications in the diagnosis of 
sphingolipidoses) 
 The investigation of the sphingolipid degradation pathway in living cells using stable 
isotopes or atypical fatty acid labeling 
 Sphingolipid isoform profiling, which is a useful tool for diagnosing disorders 
associated with Gb3Cer and sulfatide storage. 
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2. Electrospray ionization tandem mass spectrometry of sphingolipids 
The equipment used was an AB/MDS SCIEX API 3200 triple quadrupole mass 
spectrometer. Multiple reaction monitoring was used in positive (neutral 
glycosphingolipids) and negative (acidic glycosphingolipids) ion mode. Superior sensitivity 
and selectivity were exhibited when the technique was used in conjunction with normal 
phase HPLC separation. 
2.1 Electrospray ionization 
Electrospray ionization abbreviated as ESI is one of the soft ionization methods used in mass 
spectrometry (Cole, 2010; de Hoffman & Stroobant, 2002). A strong electric field is applied to 
the analyte solution as it passes through a metal capillary at atmospheric pressure. This field 
is created using a high voltage (a voltage of up to 6kV) between the capillary tip and the 
counterelectrode.  Droplets of analyte are formed under these conditions on the capillary tip, 
with ions generated and sorted on the surface. Cations are formed in positive ion mode and 
anions in negative ion mode. The generation of ions results from the electrochemical 





Fig. 2. Scheme of electrospray ionization process. 
Droplets flow in the direction of the electric field and shrink in size as the solvent 
evaporates. When the accumulated surface charge of a droplet exceeds the surface tension 
force, the droplet breaks into smaller droplets via Rayleigh fission. This process is repeated 
until the ions on the surface of the droplet are able to overcome the forces holding them, at 
which point molecular ions are formed (Fig. 2) (Cole, 2010; de Hoffman & Stroobant, 2002; 
Dulcks & Juraschek, 1999).  
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The distribution of compounds on the droplet surface results from their relative 
concentration and solubility. Less soluble compounds tend to be on the surface rather than 
in the bulk of the solution, which affects their ionization efficiency. The surface of each 
droplet is limited; thus, the concentration is more important than the total amount of the 
compound injected in the source (Cole, 2010; de Hoffman & Stroobant, 2002).  
Matrix effects occur when additional compound ions are generated on the surface. These 
compounds can completely mask the analyte (Fig. 3). The salt concentration has a similar 
effect on ionization; the maximum tolerable concentration of salts is approximately 10-3M 
(Cole, 2010; de Hoffman & Stroobant, 2002).  
The matrix effect can negatively influence electrospray ionization. It is important to choose a 
sample preparation technique that removes interfering compounds. The use of HPLC or 
capillary electrophoresis separation prior to electrospray ionization can minimize the matrix 
effect (Cole, 2010; Micova, et al., 2010); indeed, we saw a 10-fold increase in signal intensity 
when HPLC was used (data not shown). Established methods of evaluating matrix effects 
are described in the literature (Taylor, 2005).  
 
 
Fig. 3. Matrix effect interference in electrospray ionization conducted on a urinary sample. 
Total ion current (TIC) of ceramide, ceramide dihexoside and sphingomyelin. Red line: 
urinary sample after Folch extraction without purification. Visible signal decrease was 
caused by matrix effect. Blue line: sample after the purification process, which removed the 
matrix effects. 
2.2 Quadrupole mass spectrometer 
The quadrupole is a device that uses the stability of ion trajectories in oscillating electric 
fields to separate ions according to their m/z ratio (de Hoffman & Stroobant, 2002).  
The device consists of four parallel circular or hyperbolic metal rods to which 
radiofrequency voltage (RF) and direct current (DC) are applied. The total electric field is 
composed of quadrupolar alternative fields superposed on a constant field resulting from 
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the application of potential on the rods. The result is a mass filter used to separate ions 
according to their m/z ratio (de Hoffman & Stroobant, 2002; Douglas, 2009). 
The mathematical description of the total electric field is based on Mathieu equations (de 
Hoffman & Stroobant, 2002; Douglas, 2009). The equations can be used to generate a 
stability diagram for ions in the field. Direct current voltage (U) and radiofrequency voltage 
amplitude (V) are the only variables in the equations used to define ion position in these 
diagrams. The other parameters are constants, including the mass and the charge. Thus, 
changes in U and V determine a given ion’s position in the diagram. Only ions in the stable 
region are able to pass the quadrupole mass filter through the stable trajectories. By 
continually changing U and V, the quadrupole mass spectrometer is able to scan for ions 
with different m/z ratios (Fig. 4). 
 
 
Fig. 4. A quadrupolar mass filter and the trajectories of two ions. Red line: an ion in an 
unstable region of the stability diagram on an unstable trajectory. Blue line: an ion in a stable 
region of the stability diagram passing the quadrupole on a stable trajectory. A) Section of 
the quadrupole illustrating radiofrequency voltage; B) Upper side view of the ion 
trajectories in the quadrupole.  
Practically speaking, quadrupole mass spectrometers are hampered by mass resolution and 
mass range limitations. The useful level of resolution is one mass unit, and the highest 
detectable m/z is 4000 (de Hoffman & Stroobant, 2002; McLuckey & Wells, 2001).  
2.3 Triple quadrupole tandem mass spectrometry 
Triple quadrupole tandem mass spectrometry uses three quadrupoles in a series. The first 
and third quadrupoles function as mass analyzers, whereas the middle quadrupole, with 
only the radio frequency voltage used, is employed as a collision cell that does not separate 
ions according to their m/z ratios. Instead, it works as an ion channel that systematically 
returns ions to the center of the rods (de Hoffman & Stroobant, 2002; McLuckey & Wells, 
2001). 
Collision induced dissociation is a process of changing the accelerated ion kinetic energy to 
internal energy using collisions in a collision cell filled with inert gas (N2, Ar, or He). 
Analyte fragments are produced if the volume of accumulated internal energy is greater 
than the energy of the chemical bonds in the molecule (Cole, 2010; de Hoffman & Stroobant, 
2002; McLuckey & Wells, 2001; Sleno & Volmer, 2004).  
www.intechopen.com
Tandem Mass Spectrometry of Sphingolipids: Application  
in Metabolic Studies and Diagnosis of Inherited Disorders of Sphingolipid Metabolism 
 
727 
The static mode (in which only one selected m/z is measured) and the scanning mode (in 
which a range of m/z ratios is measured) are both used with the first and third quadrupole 
to attain four specific types of measurement (Cole, 2010; de Hoffman & Stroobant, 2002; 
McLuckey & Wells, 2001; Sleno & Volmer, 2004): 
1. Product ion scans. To attain these measurements, the first quadrupole is used in the 
static mode, whereas the third quadrupole is used to scan products of collision induced 
dissociation. 
2. Precursor ion scans. To attain these measurements, the first quadrupole is used in scanning 
mode to determine the mass range of precursor ions which are fragmented in the process of 
collision induced dissociation. The third quadrupole functions in static mode and is set on 
the m/z value of the selected fragment which is usually structure specific. 
3. Neutral loss scans. The technique used for this purpose monitors the loss of neutral 
fragments. The first and third quadrupoles are used for scanning with a constant mass 
offset that represents the neutral fragment loss. 
4. Single or multiple reaction monitoring. Here, the first and third quadrupoles work in 
the static mode and scan the m/z values of the analyte and its selected fragment. A pair 
of precursor-product ions of this type is called a transition pair. This technique is used 
extensively in quantitative analysis because it yields the greatest possible measurement 
sensitivity. 
Tandem mass spectrometry exhibits higher selectivity and sensitivity (with a higher signal-
to-noise ratio because noise is suppressed) than does simple mass spectrometry. This 
advantage also makes this technique useful when tandem mass spectrometry is coupled 
with HPLC separation (Haynes, et al., 2009; Sullards, et al., 2011). 
2.4 Tandem mass spectrometry of sphingolipids: ionisation, fragmentation and 
specificity of sphingolipid analysis 
2.4.1 Ionization 
The ionization of sphingolipids by electrospray ionization varies for different classes of 
sphingolipids. This variation can be used in intrasource separation in lipid analyses (Han & 
Gross, 2005; Haynes, et al., 2009). 
Neutral sphingolipids are usually protonated by ammonium formiate, ammonium acetate, 
formic or acetic acid. Ammonium salts exhibit the highest degree of ionization efficiency 
and are widely used (Mano, et al., 1997). Neutral salts of Li+ or Na+ are also used for 
ionization and generate ion-lipid adducts (Boscaro, et al., 2002; Olling, et al., 1998).  
Acids are generally used for H+ transfer in solution to basic groups on analyte or to creation 
of cluster of protonated solvents which later transfer H+ to analyte in the process of charge 
separation. On the other hand neutral amonium salts are usually added to the solution to 
facilitate the analysis of polar and neutral analytes by adduct formation and later 
protonation in the process of ionization through gas-phase reactions. Sodium and lithium 
aducts are also aded in form of neutral salts; the ionisation process has the character of 
specific charge separation (Cech & Enke, 2001; Kebarle, 2000). 
We found that for positive ion mode measurements,  5 mM ammonium formiate is a more 
efficient additive for use in sphingolipid ionization than is ammonium acetate. However, 
when using HPLC combined with mass spectrometry, we prefer to use ammonium acetate 
and acetic acid because of their better solubility in methanol.  The ions generated during the 
electrospray ionization process were [M+H]+.  
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Acidic sphingolipids, such as sulfatides or gangliosides, have acidic groups that lose H+ 
even in pure methanol. It is also possible to create chloride adducts (Han & Gross, 2005) 
using halogenated solvents that can also abstract protons (Cech & Enke, 2001).  
For measurements in negative ion mode, we used pure methanol solvent to generate [M-H]- 
ions. 
2.4.2 Fragmentation 
Fragmentation studies of sphingolipids revealed characteristic fragments useful for tandem 
mass spectrometric analysis (Domon & Costello, 1988; Fuller, et al., 2005; Gu, et al., 1997; 
Hsu, et al., 1998; Hsu & Turk, 2000; Ii, et al., 1995; Kerwin, et al., 1994; Liebisch, et al., 1999; 
Mano, et al., 1997; Murphy, et al., 2001; Olling, et al., 1998; Whitfield, et al., 2001). The most 
common fragments used for sphingolipid analysis in positive ion mode are structurally 
derived from ceramide with C18:1 sphingosine. When the amide bond is broken, followed 
by the formation of ion derived from sphingoid structure minus one water molecule, the 
fragment with the m/z value of 282 is produced. If another molecule of water is lost, the 
fragment with the m/z value of 264 is generated (Fig. 5A) (Gu, et al., 1997; Liebisch, et al., 
1999; Murphy, et al., 2001; Olling, et al., 1998). These product ions have different uses. The 
264 m/z fragments are used to analyze sphingolipids, whereas the 282 m/z  fragments are 
used to analyze N-deacylated sphingolipids (lysoderivatives) (Gu, et al., 1997; Lieser, et al., 
2003; Olling, et al., 1998; Scherer, et al., 2010).  
The ceramide fragments mentioned above are commonly used in tandem mass analysis, but 
other specific sphingolipid structures can also be used for this purpose. Sphingomyelin has 
characteristic phosphocholines that generate fragments with an m/z value of 184 (Fig. 5B) 
(Hsu & Turk, 2000; Kerwin, et al., 1994; Murphy, et al., 2001). Sialic acid is another example 
of a specific sphingolipid structure that is a component of gangliosides. Fragments of sialic 
acid have m/z values of 290 and 308 (Fig. 5C) (Domon & Costello, 1988; Ii, et al., 1995). A 
structure that is specific to sulfatides is the sulfate group, which exhibit an m/z value of 97. 
(Fig. 5D) (Hsu, et al., 1998; Whitfield, et al., 2001). 
 
 
Fig. 5. Fragmentation of ceramide (A) and specific fragments of sphingomyelin (B), GM1 
ganglioside (C) and sulphatides (D). Neutral fragment of hexose (galactose) is an example of 
fragmentation used in a neutral loss scan (E). 
Another analytical approach involves scanning for the neutral loss of saccharides from 
oligosaccharide chains of glycosphingolipids (Fig. 5E and 6) (Boscaro, et al., 2002; Domon & 
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Costello, 1988; Olling, et al., 1998). In this approach, transition pairs consisting of analyzed 
glycosphingolipids and their products with shorter or missing oligosaccharides are 
measured (Fig. 6).   
Neutral loss scanning is the technique of choice for glycosphingolipids containing 
dihydroceramide or sphinganine. Saturating the double bonds of sphing-4-enine reduces the 
production of sphingoid base fragments (Fig. 5A) in the positive mode, yielding a 
fragmentation (Fig. 6) efficiency of approximately 2-3%. In contrast, neutral loss scan 
fragmentation efficiency for the above-mentioned molecules is 10-15%. It is therefore crucial 
to select the best fragment to conduct a successful tandem mass analysis of sphingolipids. 
 
 
Fig. 6. Principle of neutral loss measurements of sphingolipids with deuterated 
dihydroceramide and sphing-4-anine in the ceramide region of the molecule. A) Complete 
loss of Gb3Cer oligosaccharide, B) Shortening of Gb3Cer oligosaccharide C) Neutral loss of 
saccharide part in lysoglycosphingolipids. CID – collision induced dissociation; Gb3Cer – 
globotriaosylceramide. 
2.4.3 Specificity of mass spectrometry analysis of sphingolipids 
Mass spectrometry analyzes molecules according to their m/z values. Different classes of 
sphingolipids are not represented by one specific molecule; rather, they are a heterogeneous 
group of molecules with different molecular masses. Their variability is mostly represented 
by a spectrum of fatty acids that form ceramide structures. Molecular species of individual 
sphingolipids are called isoforms, and their profiles are usually cell- and tissue-specific (Fig. 
7). Therefore, it is important to determine the specific isoform profiles of sphingolipids in 
biological material before conducting a quantitative analysis. 
2.5 Sample preparation for tandem mass spectrometric analysis 
A common step in the processing of different biological samples (urine, plasma, 
cerebrospinal fluid, cells, bioptic or autoptic tissues, etc.) prior to tandem mass 
spectrometric analysis is the preparation of a lipid extract.  Cells and tissues are 
homogenized, and aliquots of homogenate are usually taken for protein determination. 
Many extraction procedures have been introduced over the years, most of which have been 
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based on chloroform-methanol mixtures (Bligh & Dyer, 1959; Folch, et al., 1957) or less 
harmful solvents such as 2-propanol, ethylacetate, hexane or tetrahydrofuran (Heitmann, et 
al., 1996). The first approach remains the most popular and efficient. Widely used variations 
on the above-mentioned procedures and recommended methods of removing contaminants 
from total lipid extract were summarized by Schnaar R (Schnaar, 1994) and van Echten-
Deckerd G (van Echten-Deckert, 2000). 
 
 
Fig. 7. Isoform profiles measured using precursor ion scans for different lipids and 
biological materials. Three-milligram protein aliquots of lipid extracts were dissolved in 
methanol with 5 mM ammonium formiate and measured using 1 min precursor ion scans 
for ceramide fragments with m/z values of 264 in positive ion mode. Isoforms with different 
fatty acid chain lengths are identified. A) ceramides in skin fibroblasts, B) Gb3Cer in the 
kidney.  
2.5.1 Preparation of lipid extract from urine 
Extracts were prepared as previously published (Kuchar, et al., 2009). First, 150 µl of 
sonicated urine was extracted with 700 µl of chloroform:methanol (2:1, v:v) containing  
internal standards in a polypropylene Eppendorf tube. Then, after 15 min of repeated 
vortexing at 5 min intervals, 150 µl of MilliQ water was added. The vortex mixing procedure 
was repeated for another 15 min. After a 20 min pause, the samples were centrifuged for 5 
min at 14 000 x g. The lower organic layer was isolated using a Hamilton syringe and 
filtered using hydrophilic polytetrafluorethylene (PTFE) syringe filters. The samples were 
purified after the addition of 500 µl of MilliQ water and 15 min of vortexing. The organic 
and aqueous phases were separated by 5 min of centrifugation at 14 000 x g, and interfering 
salts and small organic molecules were removed with the upper water layer. The lower 
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organic layer containing the sphingolipids was collected, dried under a stream of nitrogen 
and stored in a freezer (-20°C). 
2.5.2 Preparation of lipid extract from cultured fibroblasts 
Fibroblast pellets were extracted by standard procedures using a 
chloroform:methanol:water mixtures as previously described (Asfaw, et al., 1998). The 
harvested cells from the 75 cm2 cultivation flask were homogenized in 250 µl of MilliQ water 
by sonication. Next, 50 µl of homogenate was used for protein determination (Hartree, 
1972). The remaining 200 µl of cell homogenate was mixed with 800 µl of 
chloroform:methanol (2:1, v/v) in a 15 ml glass tube. The mixture was rigorously vortexed 
twice for 1 min followed by a 15 min settling time at laboratory temperature. The organic 
and water layers were then separated during 10 min of centrifugation at 400 x g. The upper 
water and lower organic layers were collected, and the precipitated protein was left in the 
tube. The protein debris was washed with 500 µl of chloroform:methanol (2:1, v/v), and the 
organic layer without protein was added to the previously collected phases. The lipid 
extracts were dried under a stream of nitrogen and redissolved in 400 µl of 
chloroform:methanol (2:1, v/v).  The extracts were then filtered using hydrophilic 
polytetrafluorethylene syringe pump filters. The filtrates were dried under a stream of 
nitrogen and stored in a freezer (-20°C) for processing. 
2.5.3 Preparation of lipid extract from tissues 
The basic procedures used in the tissue extraction process were generally the same as 
those used by Natomi H (Natomi, et al., 1988), though minor modifications were made. 
Tissue samples with a wet weight of up to 0.5 g were weighed and homogenized in water 
or methanol:water (10:1, v/v). Small portions of the homogenate were stored for protein 
quantification (Hartree, 1972), and the remaining portion was used to prepare the lipid 
extracts. Chloroform was added to the methanol:water homogenate to get a ratio of 
chloroform:methanol:water (20:10:1 v/v/v). After vortexing and sonication, the extracted 
samples were centrifuged and the supernatant collected. The sediment was reextracted 
with a more polar solvent mixture of chloroform, methanol, and water (10:20:1, v/v/v) 
and then with chloroform:methanol (1:1, v/v). The total volume of the extraction mixture 
corresponding to 20 volumes of the original tissue sample was added during every step in 
the extraction process. The supernatants were combined, filtered and dried under a 
stream of nitrogen. Dried samples were stored at freezer (-20°C)  prior to processing and 
analysis. 
2.5.4 Processing of extracted lipid samples prior to tandem mass analysis 
Corresponding internal standards were added to the urinary samples during the extraction 
process (Kuchar, et al., 2009). The same volume of internal standards as was used for the 
urine samples was added to the appropriate aliquots of purified lipid extracts: 5 µg of 
cellular protein or 150 µg of tissue protein. Loading experiments with specifically labeled 
sphingolipid isoforms required 50 µg protein aliquots. 
Finally, the samples were dried under a stream of nitrogen and dissolved in methanol with 
5 mM ammonium formiate for measurement in the positive ion mode or in pure methanol 
for measurement in the negative ion mode. 
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2.6 Quantitative analysis of sphingolipids by tandem mass spectrometry  
We used an AB/MDS SCIEX API 3200 triple quadrupole mass spectrometer equipped with 
an Agilent 1100 series LC system with an autosampler. The Analyst software version 1.5 
was used to operate the hardware and process the measured data. Optimizations of 
electrospray ionization and tandem mass spectrometry conditions were conducted for each 
analyzed sphingolipid (Tab. 2).  A standard lipid solution with a sphingolipid concentration 
of 5 µg/ml, was used in the optimization process. For positive ion measurement, 5 mM 
ammonium formiate in methanol was used to produce [M+H]+ ions. To generate [M-H]- 
ions in negative ion mode, pure methanol was used. 
We measured lipids using a flow injection analysis of 20 µl sample aliquots samples. We 
used pure methanol as the mobile phase with a flow rate of 50 µl/min. One lipid was 
analyzed during one injection to provide the best possible quantitative data. The scan time 
for a transition pair was usually 100 ms but in some cases was increased to 500 ms for higher 
sensitivity. The settling time was usually 0 ms. However, it was necessary to increase this 
parameter to 500-700 ms when the ion optics setting was changed to measure more than one 
class of sphingolipid in one injection. The resolution was generally set to unit (±1 m/z), but 
in some cases, we used a high resolution setting for the first quadrupole, as using such a 




CTH CDH CMH lyso-CMH Cer 
Curtain Gas [psi] 10 10 10 10 10 
Collision Gas (N2) [psi] 3 5 5 5 5 
Ion Spray Voltage [kV] 5,5 4,5 4,5 4,5 4,5 
Temperature [°C] 200 200 200 200 200 
Ion Source Gas 1 [psi] 15 20 20 20 20 
Ion Source Gas 2 [psi] 20 55 55 55 55 
Interface Heater On On On On On 
Declustering Potential [V] 82,5 65,0 47,0 53,0 60,0 
Entrance Potential [V] 8,4 6,0 4,9 4,1 5,0 
Collision Energy [V] 77,0 64,0 48,0 31,0 42,0 
Collision Cell Exit Potential [V] 10,8 5,6 5,6 9,1 5,7 
Table 2. Example of electrospray ionization and ion optics parameters used in tandem mass 
spectrometry to analyze selected sphingolipids (Sciex API 3200, product ion m/z 264, 5 mM 
ammonium formiate in methanol). CTH – ceramidetrihexoside; CDH – ceramidedihexoside, 
CMH and lyso-CMH – ceramidemonohexoside and its N-deacylated derivative.  
Procedure of our quantitative analysis was described in a previous study (Kuchar, et al., 
2009). Problems associated with the matrix effect were addressed using internal 
standards, whereas the calibration of the method was based on an external standard. 
Quantification was performed via single-point calibration using an external calibration 
point with a standard lipid concentration (an external calibration standard) corrected by 
the signal ratio toward internal standard (mostly C17:0 isoform which is not naturally 
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abundant) isoform (mostly with C17:0 fatty acid). All standard lipid concentrations were 
within the broad range of linear response. The internal standard concentration at the 
external calibration point and in the measured samples was the same. For the 
quantification procedure, molecular species of sphingolipids with fatty acids of chain 
lengths from C16 to C26 were selected.  
2.7 Preparation of sphingolipids internal standards using enzymatic semi-synthesis 
Not all internal standards are commercially available. Thus, we developed a method of 
enzymatic semi-synthesis using immobilized sphingolipid ceramide N-deacylase 
(Pseudomonas sp, TK4) on porous magnetic cellulose (Kuchar, et al., 2010). Magnetic 
macroporous bead cellulose was used as carrier for sphingolipid ceramide N-deacylase 
(SCDase) which was immobilized using a standard procedure (Bilkova, et al., 2005; Korecka, 
et al., 2005). A 100 µl aliquot of washed settled particles was activated with 0.2 M freshly 
prepared NaIO4. The activated particles were then washed with 0.1 M phosphate buffer 
with a pH 7. Binding of 250 mI.U. of sphingolipid ceramide N-deacylase on activated 
magnetic macroporous bead cellulose was achieved by 10 min incubation in phosphate 
buffer with a pH 7. The formed Schiff base was stabilized via overnight incubation in a 
NaCNBH3 solution. The final step consisted of washing particles in phosphate buffer with a 
pH 7. Immobilized sphingolipid ceramide N-deacylase was stored in phosphate buffer with 
a pH 7  with 0.1% Triton X-100 at 4°C. 
Under specific conditions, this enzyme also catalyzes the reverse reaction (Kita, et al., 2001). 
Thus, lysoderivates can be reacylated with a specific fatty acid. Using this procedure, we 
prepared several internal standards with C17:0 fatty acids, e.g. sulfatides, 
glucosylceramides, and GM1 gangliosides. In this process, we incubated 50 nmol of lyso-
glycosphingolipid, 50 nmol of C17:0 fatty acid and immobilized sphingolipid ceramide N-
deacylase in 300 µl of pH 7 phosphate buffer with 0.1% Triton X-100 for 20 hrs at 37°C while 
mixing it on a rotator. The magnetic particles were separated, and the supernatant was 
transferred and dried under a stream of nitrogen. The quality of the prepared lipids was 
monitored by HPTLC and tandem mass spectrometry. 
2.8 Standardization of quantitative data in urine 
The results of sphingolipid quantification in cellular material are often related to protein 
concentration, a well-established standardization parameter (Liebisch, et al., 1999). Urinary 
sphingolipids mostly originate from desquamated renal tubular cells. The standardizing 
parameter commonly used for urinary metabolites is creatinine, but creatinine does not 
reflect the cellular origin of sphingolipids. Therefore, in urinary samples with a creatinine 
level lower than 1 mM, the concentration of excreted sphingolipids is artificially inflated 
(Fig. 8A), which may encourage the incorrect diagnosis of some patients with lysosomal 
storage diseases (e.g., Fabry disease, prosaposin and saposin B deficiencies, and 
sulfatidoses). Regarding Fabry disease, this issue has already been pointed out (Forni, et al., 
2009). In our experience, such diagnostic errors are especially likely to occur with newborns 
or children up to six years of age, whose normal concentration of creatinine is generally low 
(≤ 4 mM). Surprisingly, urinary volume has been found to be much more convenient for use 
as a standardization parameter (Fig. 8B). It is also possible to use the ratio of the analyzed 
compound to sphingomyelin (Berna, et al., 1999; Kuchar, et al., 2009) or phosphatidylcholine 
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(Fuller, et al., 2005; Whitfield, et al., 2001), which are membrane-bound lipids that can be 
measured simultaneously in the same sample.  
 
 
Fig. 8. Comparison of two methods of standardization of urinary Gb3Cer in three groups of 
samples: in controls with low creatinine (creatinine ≤1 mM), in controls with creatinine 
within a normal range (creatinine >1 mM-15 mM) and in Fabry patients. It is most critical to 
appropriately evaluate urine control samples with low creatinine concentrations, which are 
indistinguishable from samples from patients with Fabry disease (A). The use of urine 
volume as a standardization parameter makes it possible to differentiate more appropriately 
between controls and Fabry patients (B).                    
3. Sphingolipids  in lysosomal storage disorders – mass spectrometric data 
useful for diagnosis and research 
Flow injection analysis (FIA) combined with electrospray ionization tandem mass 
spectrometry makes it possible to determine the concentration of sphingolipids in various 
biological materials: e.g. urine, cultured fibroblasts and autoptic or bioptic tissue samples 
from different lysosomal storage disorders.  
Examples of these analyses are presented in following paragraphs. 
3.1 Sphingolipids in urine 
Urine is a non-invasive diagnostic material that is of practical importance in diagnosing 
lysosomal disorders in which the storage of non-degraded substrate causes pathological 
processes in the kidneys. These disorders are characterized by the massive excretion of 
specific sphingolipids, e.g., Gb3Cer in Fabry disease (ǂ-galactosidase A deficiency due to 
mutations of the GLA gene); multiple hydrophobic sphingolipids in  complex 
sphingolipidoses, in which the defect is caused by mutations in the prosaposin gene 
(sphingolipids with a saccharide chain that is shorter than four monosaccharide units and 
ceramides are not degraded in prosaposin deficiency and Gb3Cer and sulfatides in saposin 
B deficiency due to defective activator proteins); sulfatides in metachromatic 
leukodystrophy (arylsulfatase A deficiency due to mutations of the ARSA gene) (Fuller, et 
al., 2005; Kuchar, et al., 2009; Whitfield, et al., 2001). 
We developed a method of tandem mass spectrometry quantification of urinary 
sphingolipids that can be used in pre-diagnostic screening for the lysosomal disorders 
mentioned above (Kuchar, et al., 2009). Our data are presented in Table 3. 
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Table 3. Massive excretion of urinary sphingolipids in the case of  saposin-B and prosaposin 
deficiencies and in patients  with Fabry disease and metachromatic leukodystrophy. 
pSap-d - prosaposin deficiency, SapB-d - saposin B deficiency, MLD - metachromatic 
leukodystrophy; Cer - ceramide; CTH – ceramidetrihexoside; CDH – ceramidedihexoside, 
CMH – ceramidemonohexoside SM – sphingomyelin; Gb3Cer - globotriaosylceramide 
Values are in ng/µg of protein (mean±SD). Non-degraded sphingolipids related to 
particular lysosomal storage disorders are bolded. 
Analyzing non-degraded metabolites can be very helpful in the pre-diagnosis of 
sphingolipid activator deficiencies in which routine enzymology fails to indicate deficient 
enzyme activity due to the detergents commonly used in the assays.  
Urinary Gb3Cer has been suggested as biomarker for monitoring efficiency of enzyme 
replacement therapy  of Fabry disease. Our tests in a group of Fabry male-patients showed 
however, that monitoring of this marker is not informative for all treated patients in general 
but for individual patients only (data not shown). Although excreted Gb3Cer is useful 
parameter for diagnosis, it is not reliable biomarker for clinical trials as also confirmed by 
another studies (Schiffmann, et al., 2010). Biological basis of urinary Gb3Cer and its isoforms  
is still subject of research. 
3.2 Sphingolipids in cultured fibroblasts 
Although cultured fibroblasts are not typical “storage cells,” the concentration of non-
degraded lipids increases significantly in some lysosomal storage disorders as documented 
in Table 4. Investigating sphingolipid profile can help in laboratory diagnosis of these rare 
diseases, especially among those suspected of having defective activators of lysosomal 
hydrolases. 
3.3 Sphingolipids in tissues: Gb3Cer and lyso-Gb3Cer in Fabry myocardium and 
kidney 
In some cases, a postmortem analysis of autoptic tissue has revealed metabolic defects. 
Here, we give two examples of tissue analysis that led to a final diagnosis confirmed by 
DNA analysis later on.  
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 Cer CMH CDH Gb3Cer SM 
Prosaposin def. 34,48 14,27 25,75 27,06 45,70 
saposin B def. 6,87 1,44 1,86 21,36 107,33 
Fabry disease 3,76 1,89 2,10 35,68 42,62 
Nieman-Pick A 4,15 1,67 5,63 0,51 195,17 
Control 1 6,21 3,25 5,17 0,52 68,28 
Control 2 1,18 2,67 1,37 5,17 21,04 
Table 4. Increased concentration of sphingolipids in cultured skin fibroblasts in patients 
with sphingolipid activator deficiencies (saposin-B and prosaposin deficiencies) and in 
patients with defective enzyme proteins (in Fabry disease and metachromatic 
leukodystrophy).Values are in ng/µg of protein. Cer - ceramide; CDH – 
ceramidedihexoside, CMH – ceramidemonohexoside; SM – sphingomyelin; Gb3Cer - 
globotriaosylceramide. Non-degraded sphingolipids corresponding to particular lysosomal 
storage disorders are bolded. 
The first example shows the accumulation of Gb3Cer in the kidneys of patients with Fabry 
disease and in cases of prosaposin deficiency (Tab. 5).  
 
 Cer CMH CDH Gb3Cer sulfatide SM 
Fabry disease 0,5 1,0 3,7 115,2 0,5 24,0 
Prosaposin def. 39,1 23,9 49,8 57,6 39,6 125,8 
Control (n=3) 11,2 0,7 3,2 10,2 1,1 57,9 
Table 5. Concentration of sphingolipids in the kidneys of Fabry male patient and in a case of 
prosaposin deficiency. Values are in ng/µg of protein, Control is represented by the mean 
value. Cer - ceramide; CDH – ceramidedihexoside, CMH – ceramidemonohexoside, SM – 
shingomyelin; Gb3Cer - globotriaosylceramide. Non-degraded sphingolipids related to 
particular lysosomal storage disorders are bolded. 
Another example demonstrates the storage of Gb3Cer and lyso-Gb3Cer 
(globotriaosylsphingosine) in the myocardium of Fabry patient (Fig. 9). It is possible that the 
role of these derivates has been underrated (Dekker, et al., 2011). The role of lyso-Gb3Cer as 
a molecule that stimulates smooth muscle cell proliferation is now known. These findings 
indicate the possible role of lyso-Gb3Cer as a signal molecule (Aerts, et al., 2008). 
4. The investigation of sphingolipid degradation pathways  
4.1 Loading experiments on living cells using lipid substrates labeled with a stable 
isotope or containing atypical fatty acids  
Loading experiments in cell cultures (also called feeding experiments) are frequently used to 
investigate the metabolic fate of exogenous compounds in living model systems. The main 
advantage of such experiments is that they assess the entire degradation system, including 
any nonenzymatic cofactors.  
This method can be used to conduct a general analysis of metabolic pathways 
(Schwarzmann, et al., 1983; Sonderfeld, et al., 1985), intracellular transport or a distribution 
(Martin & Pagano, 1994) assessment of residual activity in enzyme-deficient cells 
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Fig. 9. Gb3Cer and lyso-Gb3Cer (globotriaosylsphingosine) in the myocardium of Fabry 
patient. A) Precursor ion spectrum of Gb3Cer molecular species in control myocardium. The 
spectrum was measured by a 1 min scan of a 3 mg protein aliquot of lipid extract dissolved 
in methanol with 5 mM ammonium formiate. The increased concentration of B) Gb3Cer and 
C) lyso-Gb3Cer is visible in the autoptic myocardium of Fabry patient in comparison to that 
of an age-matched control. Quantity was measured by flow injection analysis electrospray 
ionization tandem mass spectrometry using an multiple reaction monitoring scan. C17:0 
Gb3Cer was used as the internal standard for lyso-Gb3Cer quantification similarly as 
described in (Mills, et al., 2005). Concentrations were measured by method with coefficient 
of variation - CV <7%. 
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(Leinekugel, et al., 1992; Porter, et al., 1971). The method can also be used to diagnose  
storage disorders.  
This technique has been used to distinguish between metachromatic leukodystrophy and 
arylsulfatase A pseudodeficiency (Kihara, et al., 1980) and to identify deficiencies in 
nonenzymatic protein cofactors of lysosomal glycolipid catabolism (sphingolipid activator 
proteins) (Klein, et al., 1994; Schepers, et al., 1996; Schmid, et al., 1992; Sonderfeld, et al., 
1985; Wrobe, et al., 2000), including prosaposin deficiency (Harzer, et al., 1989; Chatelut, et 
al., 1997).  
In these experiments, the degradation products of labeled exogenous lipid substrates are 
determined using specific analytical methods. Traditionally, sphingolipids are labeled with 
radioisotopes, and their degradation products are separated chromatographically and 
traced using radioactivity assays. Recently, radiolabeled sphingolipids are often replaced by 
non-radioactive analogues with atypical molecular masses that can be analyzed by tandem 
mass analysis.  
Sphingolipids can be labeled on different parts of the molecule using non-natural fatty acids, 
creating molecules with atypical m/z values. However, only a few labeled standards are 
commercially available. Sphingoids can also be deuterium labeled at the double bond to 
increase mass, but the fragmentation patterns will be altered (see Fragmentation, Fig. 6).  
We compared the radioisotope and mass labeling methods in loading experiments involving 
fibroblast cultures from patients with inherited lysosomal storage diseases such as GM1 
gangliosidosis. In this study, genetic variants of the GLB1 (ß-galactosidase; ß-gal) gene were 
selected. Both approaches, the use of [3H]GM1 ganglioside and the use of its C18:0-D3 
analogue, clearly showed that the impaired degradation of critical glycosphingolipids 
resulted from defects in ǃ-gal function, as indicated in Fig. 10. 
The experiments conducted with stable isotope-labeled substrates and tandem mass 
spectrometry facilitated a more accurate quantification analysis of the lipids, and the results 
were better correlated with the clinical and biochemical phenotypes of the samples. The 
procedure used to prepare the cellular lipids for tandem mass spectrometry analysis was 
simple and relatively rapid; unlike radioisotope assays, it did not require separation during 
the pre-analytical phase (Asfaw, et al., 2002; 1998). However, experiments with radiolabeled 
glycolipid substrates indicate the entire metabolic pattern (Fig 10A) and can thus make it 
possible to identify relevant metabolites to be further analyzed via tandem mass 
spectrometry.  
Results similar to those obtained in analyzing the GM1 gangliosidosis were obtained by 
loading experiments using Gaucher fibroblasts and fibroblasts from patients with 
prosaposin deficiencies (data not shown). 
4.2 Tandem mass determination of in vitro acid glycosidase activity 
Enzymology, in combination with tandem mass spectrometry, is useful in lysosomal storage 
disorders screening and in evaluations of enzyme activity (Kasper, et al., 2010; Li, et al., 
2004; Spacil, et al., 2011; Turecek, et al., 2007). One practical application of this technique is 
the analysis of lysosomal ǃ-glucocerebrosidase activity using glucosylceramide with C12:0  
fatty acid as the enzyme substrate. Tandem mass spectrometry evaluation techniques can be 
used with cells and tissue homogenates but also with dried blood spots as the screening 
material.  
We followed Turecek´s method (Turecek, et al., 2007) in measuring lysosomal ǃ-
glucocerebrosidase activity in homogenates of cultured skin fibroblasts. The reaction  
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Fig. 10. In situ degradation of GM1 ganglioside by skin fibroblasts from control and  
ǃ-galactosidase deficient patients. Tritium-labeled glycolipid GM1 ganglioside or a C18:0-D3 
analogue was added to the culture of skin fibroblasts in 25 cm2 flasks. After 5 days, cells 
were harvested and lipids extracted. The radio-labeled lipid extracts were separated via TLC 
and analyzed using a linear scanner (Asfaw, et al., 1998), whereas the GM1 ganglioside with 
C18:0-D3 fatty acid and its degradation products were extracted and directly analyzed 
directly in tandem mass spectrometry (details in Materials and Methods). A: Degradation 
pattern of [3H]GM1 ganglioside in control and ǃ-galactosidase-deficient cells. The 
chromatographic positions of the products are indicated by the number of sugar residues on 
the glycolipid, which range from 0 (ceramide) to 4 (tetrahexosylceramide). B: Quantification 
of degradation products of [3H]GM1 ganglioside (sum of all products on the TLC plate) in  
skin fibroblasts from the control and the different ǃ-galactosidase-deficient genetic variants. 
The cell lines are arranged according to clinical phenotypes of GM1 gangliosidosis: a-
control, b-adult GM1 gangliosidosis, c-Morquio B, d-adult GM1 gangliosidosis /Morquio B, 
e-juvenile GM1 gangliosidosis, f-infantile GM1 gangliosidosis, and g-infantile GM1 
gangliosidosis. C: Quantification of GlcCer product formed from stable isotope-labeled GM1 
ganglioside (C18:0-D3) in the same cell lines as the radioactive analogue (B). Values are 
average of two samples.  
www.intechopen.com
 
Tandem Mass Spectrometry – Applications and Principles 
 
740 
mixture contained 0.5 µg of sample protein and 0.05% inactivated bovine serum albumin 
(BSA) to stabilize the enzyme. The mass spectrometry settings were optimized to prevent 
the artificial conversion of the substrate into the enzyme reaction product. An example of 
























Fig. 11. Activity of lysosomal acid ǃ-glucocerebrosidase in Gaucher and control fibroblasts 
as measured with natural substrate C12:0 glucosylceramide. The reaction product was 
analyzed by flow injection analysis electrospray ionization tandem mass spectrometry using 
a multiple reaction monitoring. 
Nowadays, procedures are simplified by skipping laborious process of extraction of reaction 
mixture after incubation. Instead, HPLC is combined with mass spectrometry. The HPLC 
step purifies the sample, removing any potential interfering compounds (Kasper, et al., 2010; 
Spacil, et al., 2011). 
5. Sphingolipid isoform profiling – a useful metabolomic approach to 
disorders involving Gb3Cer and sulfatide storage 
Tandem mass spectrometry has advantages over HPLC and other analytical methods in 
helping to determine the individual molecular species (isoforms) of sphingolipids. Changes 
in isoform profiles may provide diagnostically important information and indicate specific 
pathological processes (Fauler, et al., 2005; Paschke, et al., 2011). For example, an analysis of 
urinary lipid extracts in a case of metachromatic leukodystrophy showed significant 
differences in sulfatide isoform profiles; such differences were also evident in cases of 
prosaposin and saposin B deficiency, two other sulfatide storage disorders. We also found 
changed patterns of globotriaosylceramide species in the urine of Fabry patients and 
patients with prosaposin gene defects. A shift in the isoform pattern to species with longer 
chain fatty acids was characteristic of both prosaposin and saposin B deficiencies. 
The results presented in Table 6 were evaluated by determining the ratio of the various 
isoforms to the C18:0 isoform, which is invariable in the profile. The major advantages of 
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this procedure include simple sample preparation without internal standard and a simple 
data collection process; only a small number of transitions must be measured.  The elevation 
of certain molecular species, particularly those with longer, hydroxylated chains (in the case 
of the sulfatides), is clearly demonstrated.  
 
 
Table 6. Changed signal ratios of Gb3Cer isoforms (A) and sulfatide isoforms (B) (to the 
C18:0 species) in the urine of patients with lysosomal storage disorders. The C18:0 species 
were selected as the standard invariable parameter in the isoform pattern. Changes in the 
levels of specific isoforms in patients with lysosomal storage disorders are highlighted. 
SapB-d – saposin B deficiency; pSap-d – prosaposin deficiency; Fabry – Fabry disease; MLD 
- metachromatic leukodystrophy.  
6. Conclusions 
In this chapter, we have introduced a methods of complex sphingolipid analysis, covering 
sample preparation and final tandem mass spectrometry analysis for various biological 
materials. This approach has been used in various studies of lysosomal storage disorders 
and examples showing a range of applications are presented.  
Findings in urine are very important in the pre-diagnosis of lysosomal storage disorders and 
especially in identifying defects in the protein activators of sphingolipid hydrolases. We 
have also drawn attention to the problems with evaluating urinary sphingolipids using 
creatinine and have thereby suggested a more reliable approach to standardize sphingolipid 
excretion.  
The tandem mass analysis of sphingolipids in cells and tissues is useful in diagnosing 
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important information to lipidomic studies of the cellular function of these molecules and 
their bioactive derivatives.  
The use of tandem mass spectrometry in loading experiments using labeled sphingolipids 
can increase quantification accuracy and throughput while eliminating working risk and 
restrictions by eliminating the need for radioactive analysis. Although tandem mass 
spectrometry cannot yet fully replace radioisotope methods, using this technique can 
improve the precision and specificity of the results of metabolic experiments. 
The demand for useful screening methods for lysosomal storage disorders has led to the use 
of tandem mass spectrometry in enzymology. Analyses of enzyme activity using mass 
spectrometry performed on dried blood spots are highly sensitive and specific, and dried 
samples are easy to transport. Some methods use natural substrates, which is helpful in 
research studies of enzyme function and characteristics. 
The aforementioned advantage of tandem mass spectrometry is the ability to analyze 
individual sphingolipid molecules (isoforms). Evaluation of isoform profiles can have 
diagnostic value in disorders involving storage of Gb3Cer or sulfatides. Metabolomic 
principles have a tremendous number of research applications, especially in the 
investigation of various cellular events. 
In conclusion, tandem mass spectrometry is robust and sensitive analytical procedure that is 
still evolving. The method is efficient for determining the composition of endogenous 
sphingolipid classes in various biological materials and following their metabolic fate. Its 
ability to establish the metabolomic profiles of sphingolipids under normal and abnormal 
conditions contributes to a better understanding of the biological significance of 
sphingolipid molecules.  
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